Marek Ciszewski, JD is an accomplished corporate development professional with multi-decade experience as a biopharma analyst and portfolio manager, specialized in the valuation and financial modeling within the healthcare sector. He is an expert in private and public capital markets, having established expansive relationships with buy-side and sell-side organizations throughout his career. His accomplished track record of strategic development and entrepreneurial spirit makes him a valuable asset to organizations seeking to grow and expand their footprint within the industry. He is currently the Head of Investor Relations at Lantern Pharma Inc. (Nasdaq: LTRN), following leadership positions at companies such as Gateway Advisors, EPIRUS Biopharmaceuticals, and Verastem Oncology among others. In addition to his business acumen, Marek is also a licensed attorney, bringing a unique perspective to the intersection of corporate law, finance, securities law, and intellectual property.